Mesa Laboratories Inc
NASDAQ:MLAB

Watchlist Manager
Mesa Laboratories Inc Logo
Mesa Laboratories Inc
NASDAQ:MLAB
Watchlist
Price: 96.9 USD -4.32% Market Closed
Market Cap: $534.9m

Mesa Laboratories Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Mesa Laboratories Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Mesa Laboratories Inc
NASDAQ:MLAB
Revenue
$247.5m
CAGR 3-Years
4%
CAGR 5-Years
14%
CAGR 10-Years
12%
Boston Scientific Corp
NYSE:BSX
Revenue
$20.1B
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
10%
Edwards Lifesciences Corp
NYSE:EW
Revenue
$6.1B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
9%
Stryker Corp
NYSE:SYK
Revenue
$25.1B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Revenue
$45.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$10.1B
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
15%
No Stocks Found

Mesa Laboratories Inc
Glance View

Market Cap
534.9m USD
Industry
Health Care

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.

MLAB Intrinsic Value
86.74 USD
Overvaluation 10%
Intrinsic Value
Price $96.9

See Also

What is Mesa Laboratories Inc's Revenue?
Revenue
247.5m USD

Based on the financial report for Dec 31, 2025, Mesa Laboratories Inc's Revenue amounts to 247.5m USD.

What is Mesa Laboratories Inc's Revenue growth rate?
Revenue CAGR 10Y
12%

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Mesa Laboratories Inc have been 4% over the past three years , 14% over the past five years , and 12% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett